Connect with us
  • Elysium

Neuro rehab technology

Green light for Medtronic device

Published

on

Rehab tech firm Medtronic has received US FDA approval for its latest deep brain stimulation product.

Its rechargeable neurostimulator, part of the Percept RC Deep Brain Stimulation (DBS) system, has potential applications for a range of neurological conditions.

The Percept range is reportedly “the only sensing-enabled DBS system on the market”, allowing the physician to personalise treatment for patients with movement disorders such as Parkinson's disease, essential tremor, and dystonia as well as epilepsy.

Amaza Reitmeier, vice president and general manager, brain modulation within the Neuromodulation business, which is part of the neuroscience portfolio at Medtronic, said: "Our DBS therapy with exclusive BrainSense technology can help control debilitating tremors for people living with Parkinson's, providing patients with the ability to physically engage in everyday moments – something many of us unintentionally take for granted.

Read this and more exclusive content every day as an NR Times online subscriber. Just £2.99 a month, cancel anytime.


Login Join Now

HIWIN

Trending